Glycemic control in type 2 diabetic patients during the COVID-19 virus pandemic

Kanyakamon  Kunkitikad; Veerasak  Sarinnapakorn; Chaicharn  Deerochanawong; Sathit  Niramitmahapanya; Navaporn  Napartivaumnuay; Thitinan  Treesaranuwattana

doi:10.30574/gscarr.2021.9.1.0238

Authors

Kanyakamon Kunkitikad Endocrinology Unit, Department of Medicine, Rajavithi Hospital. College of Medicine, Rangsit University, Bangkok, 10400. Thailand.
Veerasak Sarinnapakorn Endocrinology Unit, Department of Medicine, Rajavithi Hospital. College of Medicine, Rangsit University, Bangkok, 10400. Thailand.
Chaicharn Deerochanawong Endocrinology Unit, Department of Medicine, Rajavithi Hospital. College of Medicine, Rangsit University, Bangkok, 10400. Thailand.
Sathit Niramitmahapanya Endocrinology Unit, Department of Medicine, Rajavithi Hospital. College of Medicine, Rangsit University, Bangkok, 10400. Thailand.
Navaporn Napartivaumnuay Endocrinology Unit, Department of Medicine, Rajavithi Hospital. College of Medicine, Rangsit University, Bangkok, 10400. Thailand.
Thitinan Treesaranuwattana Endocrinology Unit, Department of Medicine, Rajavithi Hospital. College of Medicine, Rangsit University, Bangkok, 10400. Thailand.

DOI:

https://doi.org/10.30574/gscarr.2021.9.1.0238

Keywords:

Glycemic control, Hemoglobin A1C, Fasting plasma glucose, Type 2 diabetes mellitus, Coronavirus disease 2019 (COVID-19)

Abstract

Background: The Coronavirus disease 2019 (COVID-19) disease is a pandemic disease spread worldwide and results in lifestyle changes in areas affected by COVID-19. The ongoing social distancing and lockdowns may negatively impact access to medical care and management of type 2 diabetes mellitus (T2DM). Accordingly, we examined the impact of the COVID-19 virus pandemic in Thailand on the glycemic control of patients with T2DM.

Method: This study focused on T2DM outpatients at Rajavithi Hospital. Three hundred and fifty participants were included. Baseline characteristics, data on exercise, outdoor activities, and access to foods and blood chemistries, including hemoglobin A1C (A1C) and fasting plasma glucose (FPG), were reviewed, and collected from electronic medical records before and after the COVID-19 pandemic.

Results: There was a significant increase in mean A1C (g/L) ± SD (74.8 ± 13.7 vs. 76.0 ± 15.3, p-value <0.016), the mean duration of outdoor activities (hours/day) ± SD during the COVID-19 virus pandemic was significantly decreased. (5.35 ± 4.48 vs. 4.03 ± 4.37, p-value <0.001)

Conclusion: The present study showed that mean A1C was significantly increased during the COVID-19 virus pandemic. Nevertheless, a statistical difference was not observed in FPG. The impact of quarantine, social distancing, and community containment during the epidemic on lifestyles may be the essential factor in increasing A1C.

Metrics

Metrics Loading ...

References

Verity R, Okell LC, Dorigatti I, Winskill P, Whittaker C, Imai N, et al. Estimates of the severity of coronavirus disease 2019: a model-based analysis. Lancet Infect Dis. 2020; 20(6): 669–677.

Perez-Saez J, Lauer SA, Kaiser L, Regard S, Delaporte E, Guessous I, et al. Serology-informed estimates of SARS-CoV-2 infection fatality risk in Geneva, Switzerland. Lancet Infect Dis. 2020; S1473309920305843.

Salje H, Tran Kiem C, Lefrancq N, Courtejoie N, Bosetti P, Paireau J, et al. Estimating the burden of SARS-CoV-2 in France. Science. 2020; 369(6500): 208–211.

Dechsupa S, Assawakosri S, Phakham S, Honsawek S. Positive impact of lockdown on COVID-19 outbreak in Thailand. Travel Med Infect Dis. 2020; 36: 101802.

Delen D, Eryarsoy E, Davazdahemami B. No Place like Home: Cross-National Data Analysis of the Efficacy of Social Distancing During the COVID-19 Pandemic. JMIR Public Health Surveill. 2020; 6(2): e19862.

Arias E, Anderson RN, Kung H-C, Murphy SL, Kochanek KD. Deaths: final data for 2001. Natl Vital Stat Rep Cent Dis Control Prev Natl Cent Health Stat Natl Vital Stat Syst. 2003; 52(3): 1–115.

Rajagopalan S. Serious Infections in Elderly Patients with Diabetes Mellitus. Clin Infect Dis. 2005; 40(7): 990–996.

Badawi A, Ryoo SG. Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis. Int J Infect Dis. 2016; 49: 129–133.

Xue T, Li Q, Zhang Q, Lin W, Wen J, Li L, et al. Blood glucose levels in elderly subjects with type 2 diabetes during COVID-19 outbreak: a retrospective study in a single center [Internet]. Endocrinology (including Diabetes Mellitus and Metabolic Disease). Apr 2020.

Tsubokura M, Takita M, Matsumura T, Hara K, Tanimoto T, Kobayashi K, et al. Changes in metabolic profiles after the Great East Japan Earthquake: a retrospective observational study. BMC Public Health. 2013; 13(1): 267.

Park S-D, Kim S-W, Moon JS, Lee YY, Cho NH, Lee J-H, et al. Impact of Social Distancing Due to Coronavirus Disease 2019 on the Changes in Glycosylated Hemoglobin Level in People with Type 2 Diabetes Mellitus. Diabetes Metab J. 2021; 45(1): 109–114.

Önmez A, Gamsızkan Z, Özdemir Ş, Kesikbaş E, Gökosmanoğlu F, Torun S, et al. The effect of COVID-19 lockdown on glycemic control in patients with type 2 diabetes mellitus in Turkey. Diabetes Metab Syndr Clin Res Rev. 2020; 14(6): 1963–1966.

Tornese G, Ceconi V, Monasta L, Carletti C, Faleschini E, Barbi E. Glycemic Control in Type 1 Diabetes Mellitus During COVID-19 Quarantine and the Role of In-Home Physical Activity. Diabetes Technol Ther. 2020; 22(6): 462–427.

Kittichamroen N, Dharmasaroja PA. Impact of 2011 Flood Disaster in Thailand on Glycemic Control in Patients with Diabetes Mellitus. J Med Assoc Thai. 2017; 100 (6): 36-41.

Ng J, Atkin SL, Rigby AS, Walton C, Kilpatrick ES. The effect of extensive flooding in Hull on the glycaemic control of patients with diabetes: Impact of flooding on glycaemic control. Diabet Med. 2011; 28(5): 519–524.

Ruissen MM, Regeer H, Landstra CP, Schroijen M, Jazet I, Nijhoff MF, et al. Increased stress, weight gain and less exercise in relation to glycemic control in people with type 1 and type 2 diabetes during the COVID-19 pandemic. BMJ Open Diabetes Res Care. 2021; 9(1): e002035.

American Diabetes Association. 6. Glycemic Targets: Standards of Medical Care in Diabetes—2021. Diabetes Care. 2021; 44(Supplement 1): S73–84.